Skip to main content

U of C researcher recognized for promising non-addictive pain medication

University of Calgary (File) University of Calgary (File)
Share

A new molecule developed by a Calgary researcher shows promise in treating chronic pain without the use of opioids.

Dr. Ketul Patel has developed a new medicine that targets a recently discovered pathway in the brain - called a T-type calcium channel - that stays away from the usual opioid receptors that can lead to addiction.

"They are very addictive and have serious side effects," Patel says of opioid-based medications. "In fact, they create more problems than what they solve."

So far the medicine shows no signs of either dependency or drug tolerance - it hasn't entered clinical trials yet - but could help ease some of the opioid crisis by preventing patients from becoming addicted in the first place.

"It's not a therapy for those who are already addicted. But this would be like alternative therapy, so we can avoid the abuse," Patel says.

Patel was recognized Wednesday with a Mitacs Award for Outstanding Innovation - Postdoctoral.

The underlying research was also supported from Zymedyne Therapuetics and the Government of Alberta.

CTVNews.ca Top Stories

Trump chooses anti-vaccine activist Robert F. Kennedy Jr. as health secretary

U.S. President-elect Donald Trump says he will nominate anti-vaccine activist Robert F. Kennedy Jr. to lead the Department of Health and Human Services, putting him in charge of a massive agency that oversees everything from drug, vaccine and food safety to medical research and the social safety net programs Medicare and Medicaid.

Measles cases in New Brunswick continues to climb

The number of measles cases in New Brunswick continues to climb. Officials with New Brunswick’s Department of Health said as of Thursday, the number of confirmed cases since October has reached 43.

Stay Connected